Drug Metabolism — MCQs
What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?
A factor that is likely to increase the duration of action of a drug that is partially metabolized by CYP3A4 in the liver is:
Phase 1 biotransformation includes
Glucuronide reaction is seen in
A patient is on warfarin therapy. All of the following drugs increase the risk of bleeding with warfarin except?
Bile salts undergo conjugation for enhanced solubility:
All of the following are true about glutathione, except:
Methanol toxicity causes blindness due to the formation of:
Alcohol is metabolized by all the following pathways except?
In the liver, ethanol is converted to which of the following substances?
Drug Metabolism Indian Medical PG Practice Questions and MCQs
Question 1: What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?
- A. First pass kinetics
- B. First order kinetics
- C. Zero order kinetics (Correct Answer)
- D. Second order kinetics
Explanation: ***Zero order kinetics*** - This mechanism occurs when the **metabolic enzymes become saturated at high drug concentrations**, leading to a constant amount (not a constant percentage) of drug being eliminated per unit time. - Alcohol, aspirin, and phenytoin are examples of drugs that exhibit **saturable metabolism**, transitioning from first-order to zero-order kinetics at higher doses. *First pass kinetics* - This describes the **metabolism of a drug by the liver or gut wall enzymes before it reaches systemic circulation** after oral administration. - While relevant to the oral bioavailability of these drugs, it does not describe the specific mechanism of elimination at high doses. *First order kinetics* - In this mechanism, a **constant fraction or percentage of the drug is eliminated per unit of time**, meaning the rate of elimination is directly proportional to the drug concentration. - Most drugs follow first-order kinetics at therapeutic doses because metabolizing enzymes are not saturated. *Second order kinetics* - This is a **less common pharmacokinetic model** where the rate of elimination is proportional to the square of the drug concentration or involves two reactants. - It does not typically describe the common elimination patterns of most drugs, including alcohol, aspirin, and phenytoin.
Question 2: A factor that is likely to increase the duration of action of a drug that is partially metabolized by CYP3A4 in the liver is:
- A. Chronic administration of phenobarbital with the drug
- B. Displacement from tissue binding sites by another drug
- C. Chronic administration of rifampicin
- D. Chronic administration of cimetidine with the drug (Correct Answer)
Explanation: ***Chronic administration of cimetidine with the drug*** - **Cimetidine** is a potent inhibitor of various **cytochrome P450 (CYP450) enzymes**, including **CYP3A4**. - By inhibiting the metabolism of a drug predominantly metabolized by **CYP3A4**, cimetidine will increase its plasma concentration and extend its **duration of action**. *Chronic administration of phenobarbital with the drug* - **Phenobarbital** is a strong **inducer of CYP450 enzymes**, including **CYP3A4**. - Induction would accelerate the metabolism of the drug, thus **decreasing its duration of action**, not increasing it. *Displacement from tissue binding sites by another drug* - Displacement from tissue binding sites would primarily increase the **free fraction of the drug in the plasma**, leading to a more rapid distribution to eliminating organs and potentially **shorter duration of action** if elimination is extraction-limited. - This mechanism does not directly impact the **metabolic rate** unless clearance is significantly altered through increased availability for metabolism. *Chronic administration of rifampicin* - **Rifampicin** is a potent **inducer of CYP3A4** and other CYP enzymes. - Its administration would lead to **increased metabolism** of the co-administered drug, thereby **reducing its duration of action**.
Question 3: Phase 1 biotransformation includes
- A. Reduction (Correct Answer)
- B. Methylation
- C. Acetylation
- D. Sulfate conjugation
Explanation: ***Reduction*** - **Phase 1 biotransformation reactions** are non-synthetic reactions that introduce or expose polar functional groups (e.g., -OH, -NH2, -SH) on xenobiotics to make them more water-soluble. - The three main Phase 1 reactions are **oxidation**, **reduction**, and **hydrolysis**. - These reactions typically involve **cytochrome P450 enzymes** and prepare drugs for excretion or Phase 2 conjugation. *Acetylation* - **Acetylation** is a **Phase 2 (conjugation) reaction**, not Phase 1. - Involves transfer of an acetyl group to amine-containing drugs via **N-acetyltransferase**. - Increases water solubility and facilitates excretion. *Sulfate conjugation* - **Sulfate conjugation** is a **Phase 2 (conjugation) reaction**, not Phase 1. - Involves addition of a sulfate group via **sulfotransferase enzymes**. - Significantly increases hydrophilicity for renal excretion. *Methylation* - **Methylation** is a **Phase 2 (conjugation) reaction**, not Phase 1. - Involves addition of a methyl group via **methyltransferase enzymes**. - Unlike most Phase 2 reactions, methylation may sometimes **decrease** water solubility but is still classified as conjugation.
Question 4: Glucuronide reaction is seen in
- A. Phase 2 (Correct Answer)
- B. NADPH-dependent reaction
- C. Phase 1
- D. Non enzymatic reaction
Explanation: ***Phase 2*** - **Glucuronide conjugation** is a prominent **Phase 2 biotransformation reaction** where glucuronic acid is added to a drug or metabolite. - This reaction increases the **water solubility** of xenobiotics, facilitating their excretion from the body. - Catalyzed by **UDP-glucuronosyltransferase (UGT)** enzymes using **UDP-glucuronic acid** as the donor molecule. *NADPH-dependent reaction* - **Glucuronidation does not require NADPH** as a cofactor. - **NADPH** is primarily involved in **Phase 1 reactions** catalyzed by cytochrome P450 enzymes for oxidation and reduction reactions. - The glucuronidation reaction uses **UDP-glucuronic acid**, not NADPH, as the source of the glucuronic acid moiety. *Phase 1* - **Phase 1 reactions** typically involve **oxidation**, **reduction**, or **hydrolysis**, introducing or unmasking functional groups (e.g., -OH, -SH, -NH2). - These reactions aim to make the parent compound more polar and often serve as a prelude to Phase 2 reactions. - Glucuronidation is a Phase 2 conjugation reaction, not Phase 1. *Non enzymatic reaction* - **Glucuronidation** is a highly specific **enzymatic reaction** catalyzed by UDP-glucuronosyltransferase (UGT) enzymes. - **Non-enzymatic reactions** in drug metabolism are less common and typically involve spontaneous degradation or chemical rearrangements without enzyme involvement.
Question 5: A patient is on warfarin therapy. All of the following drugs increase the risk of bleeding with warfarin except?
- A. Isoniazid
- B. Amiodarone
- C. Carbamazepine (Correct Answer)
- D. Cimetidine
Explanation: ***Carbamazepine*** - Carbamazepine **induces cytochrome P450 enzymes**, specifically **CYP3A4** and **CYP2C9**, which are responsible for warfarin metabolism. - This induction leads to a **faster metabolism of warfarin**, thus **decreasing its anticoagulant effect** and thereby reducing the risk of bleeding. *Isoniazid* - Isoniazid is an **inhibitor of cytochrome P450 enzymes**, primarily **CYP2C9**, which metabolizes the more potent S-warfarin isomer. - This inhibition **decreases warfarin metabolism**, leading to **increased anticoagulant effect** and higher risk of bleeding. *Amiodarone* - Amiodarone is a potent **inhibitor of cytochrome P450 enzymes**, significantly **CYP2C9** and **CYP3A4**. - It leads to a **reduced metabolism of warfarin**, causing **elevated INR** and an increased risk of bleeding. *Cimetidine* - Cimetidine is a known **inhibitor of various cytochrome P450 enzymes**, particularly **CYP1A2**, **CYP2C9**, and **CYP3A4**. - Its inhibitory action on warfarin metabolism results in **higher warfarin levels** and an **increased risk of bleeding**.
Question 6: Bile salts undergo conjugation for enhanced solubility:
- A. After conjugation with derived proteins
- B. After conjugation with lysine
- C. After conjugation with taurine and glycine (Correct Answer)
- D. After conjugation with betaglucuronic acid
Explanation: ***After conjugation with taurine and glycine*** - This statement accurately describes the most common conjugation pathway for bile acids, increasing their **amphipathic properties** and solubility. - Conjugation with these amino acids forms **bile salts** (e.g., glycocholate, taurocholate), which are essential for **micelle formation** and fat digestion. - This is the primary mechanism by which bile acids become bile salts with enhanced solubility. *After conjugation with betaglucuronic acid* - While bile acids do undergo conjugation for increased solubility, they are primarily conjugated with glycine or taurine, not beta-glucuronic acid. - Conjugation with beta-glucuronic acid is a common detoxification pathway for many xenobiotics and bilirubin, but not the primary method for bile acids. *After conjugation with derived proteins* - Bile salts are primarily steroid derivatives and are not conjugated with derived proteins. - The purpose of conjugation is to increase hydrophilicity, which proteins would not achieve in this context. *After conjugation with lysine* - Lysine is an amino acid but is not involved in the conjugation of bile acids. - Bile acid conjugation specifically uses the amino acids glycine and taurine.
Question 7: All of the following are true about glutathione, except:
- A. It is co-factor of various enzymes
- B. It converts hemoglobin to methemoglobin (Correct Answer)
- C. It is a tripeptide
- D. It conjugates xenobiotics
Explanation: ***It converts hemoglobin to methemoglobin*** - Glutathione is a **reducing agent** that helps protect hemoglobin from oxidation, thus **preventing** the formation of methemoglobin. - **Methemoglobin** occurs when the iron in hemoglobin is oxidized from the ferrous (Fe2+) to the ferric (Fe3+) state, which is a process glutathione actively counters. *It is co-factor of various enzymes* - Glutathione serves as a crucial **co-factor** for several enzymes, including **glutathione peroxidase**, which plays a vital role in antioxidant defense. - It participates in various **detoxification reactions** and catalyzes the reduction of harmful reactive oxygen species. *It is a tripeptide* - Glutathione is indeed a **tripeptide** composed of three amino acids: **glutamate**, **cysteine**, and **glycine**. - Its unique structure enables its diverse biological functions, including its prominent role as an antioxidant. *It conjugates xenobiotics* - Glutathione plays a critical role in **detoxifying xenobiotics** (foreign compounds) by conjugating with them, making them more water-soluble and easier to excrete. - This process is mediated by **glutathione S-transferases**, which attach glutathione to various toxic compounds.
Question 8: Methanol toxicity causes blindness due to the formation of:
- A. Formic acid (Correct Answer)
- B. Formaldehyde
- C. Lactic acid
- D. Pyruvic acid
Explanation: **Explanation:** Methanol toxicity is a classic high-yield topic in biochemistry and toxicology. The toxicity of methanol is not due to the parent compound itself, but rather its metabolic byproducts. **1. Why Formic Acid is correct:** Methanol is metabolized in the liver via two sequential oxidation steps: * **Step 1:** Methanol is converted to **Formaldehyde** by the enzyme *Alcohol Dehydrogenase*. * **Step 2:** Formaldehyde is rapidly converted to **Formic Acid (Formate)** by *Aldehyde Dehydrogenase*. While formaldehyde is transient and highly reactive, **Formic acid** is the primary metabolite responsible for clinical toxicity. It inhibits mitochondrial **Cytochrome c oxidase** (Complex IV), leading to cellular hypoxia. The retina and optic nerve are particularly sensitive to this metabolic inhibition, resulting in optic papillitis, retinal edema, and permanent **blindness**. **2. Analysis of Incorrect Options:** * **B. Formaldehyde:** Although it is the first metabolite formed, it has a very short half-life and is quickly converted to formic acid. Formic acid is the substance that actually accumulates and causes the specific ocular damage. * **C. Lactic Acid:** Methanol toxicity causes a high anion gap metabolic acidosis. While lactic acid may rise secondary to tissue hypoxia, it is not the direct cause of the specific visual toxicity. * **D. Pyruvic Acid:** This is a normal intermediate of glycolysis and is not a toxic byproduct of methanol metabolism. **Clinical Pearls for NEET-PG:** * **Antidote:** **Fomepizole** (inhibits Alcohol Dehydrogenase). Ethanol can be used as a competitive inhibitor if Fomepizole is unavailable. * **Key Lab Finding:** High Anion Gap Metabolic Acidosis (HAGMA) with an increased **Osmolar Gap**. * **Classic Presentation:** "Snowfield vision" (blurred vision) and "Putaminal necrosis" on brain imaging.
Question 9: Alcohol is metabolized by all the following pathways except?
- A. Alcohol dehydrogenase
- B. MEOS (Microsomal Ethanol Oxidizing System)
- C. Catalase
- D. Aldehyde dehydrogenase (Correct Answer)
Explanation: **Explanation:** The question asks for the pathway that does **not** metabolize alcohol (ethanol) itself. **Why Option D is the Correct Answer:** Alcohol metabolism occurs in two distinct stages. In the first stage, **Ethanol** is converted into **Acetaldehyde**. In the second stage, Acetaldehyde is converted into Acetate. **Aldehyde dehydrogenase (ALDH)** is the enzyme responsible for the *second* stage (oxidizing acetaldehyde). Therefore, while ALDH is part of the overall ethanol metabolism *chain*, it does not metabolize alcohol itself; it metabolizes its byproduct. **Why the other options are incorrect:** The following three systems are the primary pathways that directly oxidize **Ethanol to Acetaldehyde**: * **Alcohol Dehydrogenase (ADH):** The major pathway (cytosolic) responsible for the bulk of alcohol metabolism under normal conditions. It requires $NAD^+$ as a coenzyme. * **MEOS (Microsomal Ethanol Oxidizing System):** Located in the smooth endoplasmic reticulum, this pathway uses **Cytochrome P450 (specifically CYP2E1)**. It becomes significantly active at high blood alcohol levels (chronic alcoholism). * **Catalase:** A minor pathway located in **peroxisomes**. It plays a negligible role in the liver but may be involved in brain ethanol metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The conversion of ethanol to acetaldehyde by ADH is the rate-limiting step (follows **Zero-order kinetics**). * **Disulfiram (Antabuse):** Inhibits **Aldehyde Dehydrogenase**, leading to the accumulation of acetaldehyde, which causes nausea, flushing, and tachycardia. * **Methanol Poisoning:** Fomepizole is used as an antidote because it inhibits Alcohol Dehydrogenase, preventing the formation of toxic formaldehyde.
Question 10: In the liver, ethanol is converted to which of the following substances?
- A. Methanol
- B. Pyruvate
- C. Acetaldehyde (Correct Answer)
- D. Oxaloacetate
Explanation: **Explanation:** The metabolism of ethanol primarily occurs in the liver through a two-step oxidative process. In the first and rate-limiting step, ethanol is oxidized to **acetaldehyde**. This reaction is catalyzed by the enzyme **Alcohol Dehydrogenase (ADH)**, located in the cytosol, and requires **NAD+** as a cofactor. Acetaldehyde is subsequently converted into acetate by Aldehyde Dehydrogenase (ALDH) in the mitochondria. **Analysis of Options:** * **Option A (Methanol):** Methanol is a different type of alcohol (wood alcohol). It is not a metabolite of ethanol; rather, it is metabolized by the same enzyme system into toxic formaldehyde. * **Option B (Pyruvate):** Pyruvate is the end product of glycolysis. While ethanol metabolism increases the NADH/NAD+ ratio, this actually shifts the equilibrium *away* from pyruvate, converting it into lactate instead. * **Option D (Oxaloacetate):** Oxaloacetate is an intermediate of the TCA cycle. High levels of NADH produced during ethanol metabolism divert oxaloacetate toward malate, contributing to the inhibition of gluconeogenesis. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram (Antabuse):** Inhibits **ALDH**, leading to an accumulation of acetaldehyde. This causes the "Disulfiram-like reaction" (flushing, tachycardia, nausea). * **Metabolic Consequences:** The high **NADH/NAD+ ratio** generated during ethanol oxidation leads to: 1. **Hypoglycemia** (due to decreased gluconeogenesis). 2. **Lactic Acidosis** (pyruvate → lactate). 3. **Steatosis/Fatty Liver** (increased VLDL and fatty acid synthesis). * **MEOS Pathway:** In chronic alcoholics, the Microsomal Ethanol Oxidizing System (CYP2E1) is induced to handle the high ethanol load.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free